- Home
- PMT vs IMTX Comparison
PMT vs IMTX Comparison
Compare PMT & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PMT | IMTX |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | Germany |
| Employees | N/A | 423 |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PMT | IMTX |
|---|---|---|
| Price | $11.64 | $9.21 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $13.67 | ★ $19.25 |
| AVG Volume (30 Days) | ★ 816.8K | 447.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 13.63% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.92 |
| Revenue Next Year | $2.29 | $15.88 |
| P/E Ratio | $12.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.37 | $3.30 |
| 52 Week High | $14.88 | $12.41 |
Technical Indicators
Market Signals| Indicator | PMT | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 30.37 | 40.66 |
| Support Level | N/A | $8.72 |
| Resistance Level | $12.90 | $10.64 |
| Average True Range (ATR) | 0.28 | 0.58 |
| MACD | -0.03 | -0.09 |
| Stochastic Oscillator | 24.76 | 5.35 |
Price Performance
Historical ComparisonAbout PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.